Showing 821 - 840 results of 49,780 for search '(( 50 ((a decrease) OR (we decrease)) ) OR ( a ((fold decrease) OR (point decrease)) ))', query time: 1.08s Refine Results
  1. 821
  2. 822
  3. 823

    Optimal screening time point for a single colonoscopy program in the US. by Viktor Zaika (18611072)

    Published 2024
    “…<p><b>(A)</b> Reduction in life years lost, CRC incidence, mortality and total costs for different time points of a single screening colonoscopy with 100% adherence. …”
  4. 824
  5. 825

    Table_1_When and Why Did Human Brains Decrease in Size? A New Change-Point Analysis and Insights From Brain Evolution in Ants.XLSX by Jeremy M. DeSilva (7247009)

    Published 2021
    “…<p>Human brain size nearly quadrupled in the six million years since Homo last shared a common ancestor with chimpanzees, but human brains are thought to have decreased in volume since the end of the last Ice Age. …”
  6. 826

    Optimal time points for a three-colonoscopy screening program in the US. by Viktor Zaika (18611072)

    Published 2024
    “…Selected model parameters were increased and decreased by up to 50%. Dashed lines indicate average optimal points obtained for nominal simulations. …”
  7. 827

    GluN2A(D731N) decreases channel open probability. by Kai Gao (120150)

    Published 2017
    “…The di-heteromeric mutant (2A-D731N) and tri-heteromeric receptors with two-copies of the mutant subunit (D731N/D731N) showed a prolonged inhibition rate, reflecting a decreased channel open probability. …”
  8. 828

    Folding and Unfolding Movements in a [2]Pseudorotaxane by Moorthy Suresh (1908949)

    Published 2011
    “…Thus we could demonstrate that a molecular folding-unfolding type of movement in the crown ether derivative could be induced by chemical input as an imidazolium ion.…”
  9. 829
  10. 830
  11. 831
  12. 832

    A Novel Highly Potent Autotaxin/ENPP2 Inhibitor Produces Prolonged Decreases in Plasma Lysophosphatidic Acid Formation <i>In Vivo</i> and Regulates Urethral Tension by Hiroshi Saga (584103)

    Published 2014
    “…To date, several autotaxin/ENPP2 inhibitors have been reported; however, none were able to completely and continuously inhibit autotaxin/ENPP2 <i>in vivo</i>. In this study, we report the discovery of a highly potent autotaxin/ENPP2 inhibitor, ONO-8430506, which decreased plasma lysophosphatidic acid formation.…”
  13. 833
  14. 834
  15. 835
  16. 836
  17. 837
  18. 838
  19. 839
  20. 840